BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29155281)

  • 1. Effect of oregano essential oil and carvacrol on Cryptosporidium parvum infectivity in HCT-8 cells.
    Gaur S; Kuhlenschmidt TB; Kuhlenschmidt MS; Andrade JE
    Parasitol Int; 2018 Apr; 67(2):170-175. PubMed ID: 29155281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalization of Lipid-Based Nutrient Supplement with β-Cyclodextrin Inclusions of Oregano Essential Oil.
    Gaur S; Lopez EC; Ojha A; Andrade JE
    J Food Sci; 2018 Jun; 83(6):1748-1756. PubMed ID: 29771453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of thermal treatments on the viability and infectivity of Cryptosporidium parvum on beef surfaces.
    Moriarty EM; Duffy G; McEvoy JM; Caccio S; Sheridan JJ; McDowell D; Blair IS
    J Appl Microbiol; 2005; 98(3):618-23. PubMed ID: 15715864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of in vitro evaluation of chemical disinfectants for efficacy on Cryptosporidium parvum oocysts.
    Delling C; Lendner M; Müller U; Daugschies A
    Vet Parasitol; 2017 Oct; 245():5-13. PubMed ID: 28969838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of viability assays for Cryptosporidium parvum oocysts after disinfection.
    Joachim A; Eckert E; Petry F; Bialek R; Daugschies A
    Vet Parasitol; 2003 Jan; 111(1):47-57. PubMed ID: 12523978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Die-off of Cryptosporidium parvum in soil and wastewater effluents.
    Nasser AM; Tweto E; Nitzan Y
    J Appl Microbiol; 2007 Jan; 102(1):169-76. PubMed ID: 17184332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-protozoal activity of extracts from chicory (Cichorium intybus) against Cryptosporidium parvum in cell culture.
    Woolsey ID; Valente AH; Williams AR; Thamsborg SM; Simonsen HT; Enemark HL
    Sci Rep; 2019 Dec; 9(1):20414. PubMed ID: 31892721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigations of the relationship between use of in vitro cell culture-quantitative PCR and a mouse-based bioassay for evaluating critical factors affecting the disinfection performance of pulsed UV light for treating Cryptosporidium parvum oocysts in saline.
    Garvey M; Farrell H; Cormican M; Rowan N
    J Microbiol Methods; 2010 Mar; 80(3):267-73. PubMed ID: 20096310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
    Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
    Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative evaluation of infectivity change of Cryptosporidium parvum after gamma irradiation.
    Lee SU; Joung M; Nam T; Park WY; Yu JR
    Korean J Parasitol; 2009 Mar; 47(1):7-11. PubMed ID: 19290085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipases and cationic peptides inhibit Cryptosporidium parvum sporozoite infectivity by parasiticidal and non-parasiticidal mechanisms.
    Carryn S; Schaefer DA; Imboden M; Homan EJ; Bremel RD; Riggs MW
    J Parasitol; 2012 Feb; 98(1):199-204. PubMed ID: 21787211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral efficacy and mechanisms of action of oregano essential oil and its primary component carvacrol against murine norovirus.
    Gilling DH; Kitajima M; Torrey JR; Bright KR
    J Appl Microbiol; 2014 May; 116(5):1149-63. PubMed ID: 24779581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Cryptosporidium parvum development in various cell lines for screening in vitro drug testing.
    Siripanth C; Punpoowong B; Amarapal P; Thima N; Eampokalap B; Kaewkungwal J
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):540-6. PubMed ID: 15689063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Cryptosporidium parvum infection of a mammalian cell culture by recombinant scFv antibodies.
    Pokorny NJ; Boulter-Bitzer JI; Hall JC; Trevors JT; Lee H
    Antonie Van Leeuwenhoek; 2008 Oct; 94(3):353-64. PubMed ID: 18581250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Ginsenoside-Rh2 and Curcurbitacin-B on Cryptosporidium parvum in vitro.
    Shahiduzzaman M; Ras R; Widmer G
    Exp Parasitol; 2020 May; 212():107873. PubMed ID: 32165146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoproteins and Gal-GalNAc cause Cryptosporidium to switch from an invasive sporozoite to a replicative trophozoite.
    Edwinson A; Widmer G; McEvoy J
    Int J Parasitol; 2016 Jan; 46(1):67-74. PubMed ID: 26432292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of organic acids and hydrogen peroxide on Cryptosporidium parvum viability in fruit juices.
    Kniel KE; Sumner SS; Lindsay DS; Hackney CR; Pierson MD; Zajac AM; Golden DA; Fayer R
    J Food Prot; 2003 Sep; 66(9):1650-7. PubMed ID: 14503720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vitro cell culture and a mouse assay for measuring infectivity of Cryptosporidium parvum.
    Rochelle PA; Marshall MM; Mead JR; Johnson AM; Korich DG; Rosen JS; De Leon R
    Appl Environ Microbiol; 2002 Aug; 68(8):3809-17. PubMed ID: 12147476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory activity of chitosan nanoparticles against Cryptosporidium parvum oocysts.
    Ahmed SA; El-Mahallawy HS; Karanis P
    Parasitol Res; 2019 Jul; 118(7):2053-2063. PubMed ID: 31187224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.